IMPACT OF AGE ON PROGNOSIS OF LOCALLY ADVANCED HEAD AND NECK CANCER (LAHNC) TREATED WITH CHEMORADIATION (CRT). A SINGLE INSTITUTIONAL EXPERIENCE

被引：0
|
作者：
Denaro, N. [1 ]
Colantonio, I. [2 ]
Montano, M. [2 ]
Russi, E. [3 ]
Taglianti, R. Vigna [3 ]
Vitiello, R. [3 ]
Giurlanda, F. [2 ]
Miraglio, E. [4 ]
Chiarlone, M. [2 ]
Merlano, M. C. [5 ]
机构：
[1] Policlin G Martino, Messina, Italy
[2] Santa Croce & Carle Gen Hosp, Cuneo, Italy
[3] S Croce Gen Hosp, Cuneo, Italy
[4] S Croce & Carle, Cuneo, Italy
[5] St Croce Gen Hosp, Dept Med Oncol, Cuneo, Italy
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：319 / 319
页数：1
相关论文
共 50 条
  • [31] Assessment of the Role of Gefitinib With Concurrent Chemoradiation in Locally Advanced Head and Neck Cancer
    Prajapati, Raju
    Singh, Om P.
    Ghori, Hameeduzzafar
    Jatav, Jagannath
    Narwariya, Abhinav
    Yogi, Vineeta
    Ismail, Essam Elbadawy
    Shaikh, Mohammad Habeebur Raheman
    Moosa, Shajiya Sarwar
    Begum, Yousuf
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [32] Does Response to Induction Chemotherapy (IC) Predict Outcome After Concurrent Chemoradiation therapy (CCRT) in Locally Advanced Head-and-Neck Cancer (LAHNC)?
    Cotter, R.
    Gupta, V.
    Blacksburg, S.
    Carpenter, T.
    Misiukiewicz, K.
    Genden, E.
    Som, P.
    Posner, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S523 - S523
  • [33] JAVELIN Head and Neck 100: a Phase III trial of avelumab and chemoradiation for locally advanced head and neck cancer
    Yu, Yao
    Lee, Nancy Y.
    FUTURE ONCOLOGY, 2019, 15 (07) : 687 - 694
  • [34] Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).
    Powell, Steven Francis
    Gitau, Mark Mutuota
    Sumey, Christopher Joseph
    Reynolds, John T.
    Lohr, Michele
    McGraw, Steven
    Nowak, Ryan Kenneth
    Terrell, Andrew M.
    Jensen, Ashley Wayne
    Blanchard, Miran Joel
    Ellison, Christie
    Black, Lora Jane
    Thompson, Paul A.
    Gold, Kathryn A.
    Cohen, Ezra E. W.
    Lee, John H.
    Spanos, William Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] CAREGIVERS' BURDEN AND FATIGUE DURING PATIENTS' (PTS) TREATMENT WITH CURATIVE, CONCOMITANT CHEMORADIOTHERAPY (CRT) FOR LOCALLY ADVANCED HEAD AND NECK CANCER (LAHNC): A PROSPECTIVE, OBSERVATIONAL STUDY
    van Herpen, C.
    Langenberg, S. M. C. H.
    van Opstal, C. C. M.
    Wymenga, A. N. M.
    van der Graaf, W. T. A.
    Prins, J. B.
    ANNALS OF ONCOLOGY, 2014, 25
  • [36] Preoperative chemoradiation in locally advanced rectal cancer: A single center experience
    Oliveira, L.
    Rolo, A.
    Carvalho, C.
    Faustino, I.
    Alpoim, C.
    Calcada, C.
    Costa, A.
    Fonseca, G.
    Conde, J.
    Teixeira, A.
    Fardilha, C.
    Costa, P.
    Coutinho, C.
    ANNALS OF ONCOLOGY, 2018, 29 : 86 - 86
  • [37] Concurrent hypofractionated chemoradiation (CRT) for head and neck squamous cancer with weekly cisplatin: A Lancashire experience
    Sivaramalingam, M.
    Mehta, A.
    Wong, H.
    Sidek, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Addition of Nimotuzumab to Standard TPF Regimen in Locally Advanced Head and Neck Cancer: A Single Institutional Study
    Koramati, Samuel Luke
    Sarathy, Vinu
    Varayathu, Hrishi
    Thomas, Beulah Elsa
    Naik, Radheshyam
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [39] Impact of Pretreatment Inflammatory Markers in Locally Advanced Head and Neck Cancer Treated with Concurrent Chemoradiotherapy
    Pruthi, Deep Shankar
    Nagpal, Puneet
    Pandey, Manish
    Yadav, Ashu
    MIDDLE EAST JOURNAL OF CANCER, 2023, 15 (03) : 226 - 233
  • [40] Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience
    Cavalieri, Stefano
    Platini, Francesca
    Barretta, Francesco
    Nuzzolese, Imperia
    Ottini, Arianna
    Bergamini, Cristiana
    Resteghini, Carlo
    Colombo, Elena
    Iacovelli, Nicola Alessandro
    Franceschini, Marzia
    Calareso, Giuseppina
    Di Pede, Patricia
    De Feo, Giulia
    Gandelli, Monica
    Toffolatti, Luisa
    Guglielmo, Mauro
    Ripamonti, Carla Ida
    Cosmai, Laura
    Licitra, Lisa
    Alfieri, Salvatore
    ORAL ONCOLOGY, 2023, 146
12345